Michelle Y. Kite, MS (she/her/hers)

Director of Global Strategy, Oncology
Pfizer

Michelle Kite is Director of Global Regulatory Strategy, Oncology at Pfizer. With 20+ years in regulatory affairs and 16+ years at Pfizer, she has spent the last 12 years specializing in breast cancer programs, including Ibrance (palbociclib) and atirmociclib. She leads global regulatory strategy from development through lifecycle management, partnering across functions to enable patient access.

Presentation(s):

• Opening Plenary: From Data to Decisions: The Expanding Role of Real‑World Evidence in Regulatory Submissions

  Thursday, March 5, 2026
  9:00 AM - 10:00 AM East Coast USA Time